Doctor profile · Federal record

Dr. Suneya Hogarty, M.D.

Specialist (CMS: Rheumatology) · Goldsboro, NC

  • NPI 1366407686
  • Accepts Medicare
  • MIPS 72.6 / 100 · 2023
  • 27 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
2719 Graves Dr, Ste 14
Goldsboro, NC 275344536
(984) 207-9440
fax (919) 344-0257
Additional location
2704 Medical Office Pl
Goldsboro, NC 275349460
(919) 736-4724
fax (919) 736-1677

Credentials & registration

NPPES · NUCC
NPI registered
April 2006 — 20 yrs on file
Profile last updated
December 15, 2020
Year of graduation
1999 — 27 yrs since
Specialty taxonomy
174400000X — NUCC code
State license (1)
North Carolina #01018
Medicaid
NC #5902106

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1366407686. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
148,812
Distinct HCPCS
10
Medicare allowed
$2,014,892
HCPCS Description Services Patients Avg allowed
J3262 Injection, tocilizumab, 1 mg 84,888 19 $6
J1602 Injection, golimumab, 1 mg, for intravenous use 33,700 38 $13
J0897 Injection, denosumab, 1 mg 9,551 102 $23
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 8,775 14 $42
J1745 Injection, infliximab, excludes biosimilar, 10 mg 6,643 21 $33
J7322 Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg 1,344 16 $17
J7050 Infusion, normal saline solution, 250 cc 1,257 108 $1
96413 Administration of chemotherapy into vein, 1 hour or less 631 109 $123
99214 Established patient office or other outpatient visit, 30-39 minutes 491 245 $122
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 447 115 $67

In context: peer comparison

Among 1 peers in Goldsboro Specialist, average services per provider: 6,764. This provider delivers 22× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,388
Transactions
102
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen INC. 27 $515.61
AstraZeneca Pharmaceuticals Lp 10 $291.30
Abbvie INC. 11 $268.52
Ucb, INC. 10 $201.98
Novartis Pharmaceuticals Corporation 7 $174.59
GlaxoSmithKline, LLC. 8 $165.46
Mallinckrodt Hospital Products INC. 7 $147.65
Janssen Biotech, INC. 5 $126.21
Genzyme Corporation 1 $111.50
Aurinia Pharma U.S., INC. 4 $64.49
Lilly USA, LLC 3 $55.01
Pfizer INC. 3 $48.01
Scilex Pharmaceuticals INC. 2 $47.02
Boehringer Ingelheim Pharmaceuticals, INC. 2 $39.37
Ani Pharmaceuticals, INC. 2 $35.64

By nature of payment

Food and Beverage
$2,388

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,331
Patients
641
Total drug cost
$100,349
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 682 160 $41,382
Methotrexate (Methotrexate Sodium) Brand 541 143 $15,039
Leflunomide Generic 153 40 $9,157
Allopurinol Generic 149 50 $2,835
Prednisone Generic 143 46 $822
Duloxetine Hcl Generic 94 21 $1,566
Febuxostat Generic 84 21 $9,476
Celecoxib Generic 80 15 $1,458
Mycophenolate Mofetil Generic 79 26 $9,020
Tramadol Hcl Generic 79 19 $729

Frequently asked questions

Auto-generated from federal data
What is Dr. Suneya Hogarty's medical specialty?
Dr. Suneya Hogarty practices Specialist in Goldsboro, NC.
Where does Dr. Suneya Hogarty practice?
Dr. Suneya Hogarty practices at 2719 Graves Dr, Goldsboro, NC 275344536. Office phone: 9842079440.
What is Dr. Suneya Hogarty's NPI?
Dr. Suneya Hogarty's National Provider Identifier (NPI) is 1366407686, issued by NPPES.
Does Dr. Suneya Hogarty accept Medicare assignment?
Yes. Dr. Suneya Hogarty accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Suneya Hogarty commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.